Get the Stockscreener App
21.22
0.52%
-0.11
Metlife, Inc. Floating Rate Non Cuml Series A Stock (METpA) Forecast
The Metlife, Inc. Floating Rate Non Cuml Series A (METpA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $21.02, representing a -0.92% decrease from the current price of $21.22. The highest analyst price target is $21.31, and the lowest is $20.74.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month METpA Price Target
Average 19.57
(-7.79% Downside)
Is Metlife, Inc. Floating Rate Non Cuml Series A (METpA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 52.13 | Neutral |
| STOCH(9,6) | 45.44 | Neutral |
| STOCHRSI(14) | 38.37 | Neutral |
| MACD(12,26) | 0.0736 | Sell |
| ADX(14) | 8.9484 | Neutral |
| William %R | -66.67 | Neutral |
| CCI(14) | -13.66 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
21.27
Sell
|
21.26
Sell
|
| MA20 |
21.24
Sell
|
21.21
Buy
|
| MA50 |
21.03
Buy
|
21.15
Buy
|
| MA100 |
21.28
Sell
|
21.25
Sell
|
| MA200 |
21.41
Sell
|
21.60
Sell
|
Buy: 3
Sell: 7
Neutral: 0
Summary: Sell
According to our latest analysis, METpA could be considered a Moderate Sell, with 17 technical analysis indicators signaling 3 Buy signals, 8 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on METpA, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 52.13 indicates that METpA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 45.44 indicates that METpA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 38.37 indicates that METpA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 8.9484 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -13.66 indicates that METpA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term METpA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Metlife, Inc. Floating Rate Non Cuml Series A financial reports and earnings history, Metlife, Inc. Floating Rate Non Cuml Series A (METpA) stock could reach $14.07 by 2030, $10.38 by 2040 and $34.09 by 2050. See the projected annual prices until 2050 of the Metlife, Inc. Floating Rate Non Cuml Series A stock below:
- Metlife, Inc. Floating Rate Non Cuml Series A (METpA) is expected to reach an average price of $2.885 in 2035, with a high prediction of $3.3768 and a low estimate of $2.3285. This indicates an $-86.40% rise from the last recorded price of $21.22.
- Metlife, Inc. Floating Rate Non Cuml Series A (METpA) stock is projected to chart a bullish course in 2040, with an average price target of $10.46, representing an $-50.71% surge from its current level. The forecast ranges from a conservative $6.8043 to a sky-high $10.38.
- Our analysts predict Metlife, Inc. Floating Rate Non Cuml Series A (METpA) to jump 7.70% by 2045, soaring from $21.78 to an average price of $22.85, potentially reaching $22.45. While $21.78 is the low estimate, the potential upside is significant.
- Metlife, Inc. Floating Rate Non Cuml Series A (METpA) stock is expected to climb by 2050, reaching an average of $33.91, a $59.82% jump from its current level. However, a wide range of estimates exists, with high and low targets of $34.09 and $34.22, respectively, highlighting the market's uncertainty.
Metlife, Inc. Floating Rate Non Cuml Series A Stock (METpA) Year by Year Forecast
Metlife, Inc. Floating Rate Non Cuml Series A Stock (METpA) Price Forecast for 2026
The predicted value for Metlife, Inc. Floating Rate Non Cuml Series A (METpA) in 2026 is set at an average of $20.94. Estimates vary from a peak of $22.63 to a trough of $19.26, indicating an -1.30% surge from the present price of $21.22.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $21.03 | $20.74 | $21.31 | -0.88% |
| December, 2026 | $19.42 | $19.26 | $21.13 | -8.46% |
Metlife, Inc. Floating Rate Non Cuml Series A Stock (METpA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Metlife, Inc. Floating Rate Non Cuml Series A (METpA) is $18.89, with a high forecast of $19.96 and a low forecast of $17.81. This indicates an -10.99% decrease from the last price of $21.22.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $19.02 | $18.97 | $19.72 | -10.38% |
| February, 2027 | $18.94 | $18.56 | $19.22 | -10.75% |
| March, 2027 | $18.99 | $18.66 | $19.29 | -10.53% |
| April, 2027 | $18.72 | $18.52 | $19.06 | -11.79% |
| May, 2027 | $18.39 | $17.83 | $18.89 | -13.31% |
| June, 2027 | $19.13 | $18.16 | $19.13 | -9.86% |
| July, 2027 | $19.26 | $19.06 | $19.96 | -9.24% |
| August, 2027 | $18.75 | $18.35 | $19.37 | -11.66% |
| September, 2027 | $18.48 | $18.22 | $18.98 | -12.92% |
| October, 2027 | $18.60 | $17.90 | $18.92 | -12.35% |
| November, 2027 | $18.86 | $17.81 | $18.94 | -11.14% |
| December, 2027 | $18.68 | $18.47 | $19.06 | -11.98% |
Metlife, Inc. Floating Rate Non Cuml Series A Stock (METpA) Price Forecast for 2028
In 2028, Metlife, Inc. Floating Rate Non Cuml Series A (METpA) is projected to reach an average price of $16.82, with a high projection of $18.54 and a low estimate of $15.11. This indicates an -20.72% fall from the last price of $21.22.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $17.98 | $17.88 | $18.54 | -15.25% |
| February, 2028 | $17.11 | $16.91 | $18.35 | -19.38% |
| March, 2028 | $16.69 | $16.43 | $17.18 | -21.34% |
| April, 2028 | $16.21 | $15.88 | $16.80 | -23.59% |
| May, 2028 | $16.11 | $15.78 | $16.44 | -24.08% |
| June, 2028 | $16.25 | $15.85 | $16.53 | -23.41% |
| July, 2028 | $15.47 | $15.11 | $16.17 | -27.11% |
| August, 2028 | $15.78 | $15.27 | $15.89 | -25.63% |
| September, 2028 | $17.09 | $15.71 | $17.13 | -19.46% |
| October, 2028 | $15.84 | $15.71 | $17.30 | -25.35% |
| November, 2028 | $15.97 | $15.85 | $16.35 | -24.72% |
| December, 2028 | $15.49 | $15.39 | $16.06 | -27.02% |
Metlife, Inc. Floating Rate Non Cuml Series A Stock (METpA) Price Forecast for 2029
The 2029 price forecast for Metlife, Inc. Floating Rate Non Cuml Series A Stock (METpA) is $14.44 on average, with a high prediction of $16.50 and a low estimate of $12.39. This represents an -31.93% decrease from the previous price of $21.22.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $15.55 | $15.31 | $16.33 | -26.71% |
| February, 2029 | $16.12 | $15.24 | $16.50 | -24.05% |
| March, 2029 | $15.42 | $15.38 | $16.35 | -27.35% |
| April, 2029 | $15.34 | $15.03 | $15.58 | -27.72% |
| May, 2029 | $13.77 | $13.60 | $15.44 | -35.09% |
| June, 2029 | $13.41 | $13.36 | $14.09 | -36.81% |
| July, 2029 | $13.23 | $12.99 | $13.65 | -37.65% |
| August, 2029 | $13.48 | $13.24 | $13.77 | -36.49% |
| September, 2029 | $13.25 | $13.05 | $13.56 | -37.55% |
| October, 2029 | $12.98 | $12.39 | $13.44 | -38.81% |
| November, 2029 | $13.76 | $12.76 | $13.76 | -35.16% |
| December, 2029 | $13.87 | $13.71 | $14.63 | -34.63% |
Metlife, Inc. Floating Rate Non Cuml Series A Stock (METpA) Price Forecast for 2030
Metlife, Inc. Floating Rate Non Cuml Series A Stock (METpA) is expected to reach an average price of $11.87 in 2030, with a high forecast of $14.07 and a low forecast of $9.6637. This signifies an -44.08% decrease from the last price of $21.22.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $13.48 | $13.06 | $14.07 | -36.49% |
| February, 2030 | $13.25 | $12.99 | $13.72 | -37.54% |
| March, 2030 | $13.42 | $12.71 | $13.74 | -36.76% |
| April, 2030 | $13.73 | $12.67 | $13.81 | -35.29% |
| May, 2030 | $13.60 | $13.36 | $13.95 | -35.93% |
| June, 2030 | $12.36 | $12.35 | $12.79 | -41.77% |
| July, 2030 | $11.43 | $11.23 | $12.65 | -46.11% |
| August, 2030 | $11.06 | $10.77 | $11.52 | -47.87% |
| September, 2030 | $10.44 | $10.29 | $11.18 | -50.79% |
| October, 2030 | $10.58 | $10.21 | $10.80 | -50.15% |
| November, 2030 | $10.77 | $10.36 | $11.01 | -49.26% |
| December, 2030 | $10.04 | $9.6637 | $10.71 | -52.71% |
2.00%
3.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):